Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Amortizatization of Intangibles: 2022-2024

Historic Amortizatization of Intangibles for Oncology Institute (TOI) over the last 3 years, with FY2024 value amounting to $500000.0.

  • Oncology Institute's Amortizatization of Intangibles fell 9994.79% to $1000.0 in Q4 2024 from the same period last year, while for Jun 2025 it was $1000.0, marking a year-over-year decrease of 9996.29%. This contributed to the annual value of $500000.0 for FY2024, which is 8099.58% down from last year.
  • Per Oncology Institute's latest filing, its Amortizatization of Intangibles stood at $500000.0 for FY2024, which was down 8099.58% from $2.6 million recorded in FY2023.
  • In the past 5 years, Oncology Institute's Amortizatization of Intangibles ranged from a high of $2.6 million in FY2023 and a low of $500000.0 during FY2024
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $1.0 million (2022), whereas its average is $1.4 million.
  • As far as peak fluctuations go, Oncology Institute's Amortizatization of Intangibles skyrocketed by 15794.12% in 2023, and later crashed by 8099.58% in 2024.
  • Oncology Institute's Amortizatization of Intangibles (Annual) stood at $1.0 million in 2022, then soared by 157.94% to $2.6 million in 2023, then tumbled by 81.0% to $500000.0 in 2024.
  • Its Amortizatization of Intangibles stands at $500000.0 for FY2024, versus $2.6 million for FY2023 and $1.0 million for FY2022.